The evolution of survival of pulmonary arterial hypertension over 15 years

The prognosis of pulmonary arterial hypertension (PAH) remains dismal. Over the years, multiple therapeutic advances have been introduced. This study evaluates the evolution of PAH survival over the past 15 years. We included 293 consecutive adult patients diagnosed with PAH between 2005 and 2019 (m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendriks, Paul M., Staal, Diederik P., van de Groep, Liza D., van den Toorn, Leon M., Chandoesing, Prewesh P., Kauling, Robert M., Mager, Hans‐Jurgen, van den Bosch, Annemien E., Post, Marco C., Boomars, Karin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579738/
https://www.ncbi.nlm.nih.gov/pubmed/36268054
http://dx.doi.org/10.1002/pul2.12137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579738/
https://www.ncbi.nlm.nih.gov/pubmed/36268054
http://dx.doi.org/10.1002/pul2.12137

Ejemplares similares